A nurse is preparing to transfer a client who is non-weight bearing from the bed to a chair with the aid of an assistive personnel. The client is cooperative and has upper body strength. Which of the following assistive devices should the nurse use when transferring the client?

A. "Advance directives are the same as a consent form for health care treatment": Advance directives are different from a consent form. A consent form is specific to the current treatment or procedure, while advance directives outline future healthcare wishes in the event the client becomes unable to make decisions.

B. "Advance directives are for clients who have life-threatening conditions.": While advance directives are especially important for clients with serious illnesses, they are appropriate for all adults, regardless of current health status, to ensure their wishes are known and respected if they become incapacitated.

C. "Advance directives must be approved by your lawyer.": Advance directives do not require a lawyer's approval to be valid. They usually need to be signed by the client and witnessed or notarized, depending on state laws, but legal counsel is not mandatory for completing one.

D. "Advance directives protect your right to make your own health care decisions.": Advance directives ensure that a client’s wishes regarding healthcare are known and respected even if they cannot voice them later. They preserve the client’s autonomy and legal rights concerning treatment preferences.

• Frequent headaches: Phenelzine, an MAOI, can cause hypertensive crisis, with one of the earliest signs being persistent or worsening headaches. Frequent headaches must be treated as a possible warning of dangerously elevated blood pressure and require immediate provider notification.
• Elevated blood pressure (169/91 mm Hg): The significant rise in the client's blood pressure compared to baseline indicates new-onset hypertension. This is a serious adverse effect associated with MAOIs and signals the potential development of a hypertensive crisis, which must be urgently addressed.
• Difficulty sleeping: Difficulty sleeping or insomnia is a common side effect of phenelzine and other antidepressants. Although not life-threatening, insomnia can impair recovery if untreated and should be documented and discussed with the provider to adjust management if needed.
• Feeling much better: Improvement in mood and reduced fatigue are intended therapeutic outcomes of phenelzine treatment. These findings are positive signs and do not indicate an adverse reaction that needs intervention.
• Heart rate 78/min and respiratory rate 18/min: Both values are within normal ranges and do not suggest immediate concerns related to cardiovascular or respiratory function. They should continue to be monitored but do not require urgent action.